What this quiz covers
This quiz focuses on Sharps Handling, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.
A 62-year-old man (weight 88 kg) with type 2 diabetes is using insulin pens and admits he leaves the needle attached to the pen between injections to "keep it clean." Current medications: insulin glargine pen 28 units subcutaneously nightly, insulin lispro pen 8 units subcutaneously with meals, empagliflozin 25 mg orally daily, amlodipine 10 mg orally daily. Allergies: none. Labs: hemoglobin A1c 8.4%. What is the best recommendation for safe insulin pen usage?
NAPLEX Quiz
Practice Sharps Handling in NAPLEX with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
This quiz focuses on Sharps Handling, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
A 62-year-old man (weight 88 kg) with type 2 diabetes is using insulin pens and admits he leaves the needle attached to the pen between injections to "keep it clean." Current medications: insulin glargine pen 28 units subcutaneously nightly, insulin lispro pen 8 units subcutaneously with meals, empagliflozin 25 mg orally daily, amlodipine 10 mg orally daily. Allergies: none. Labs: hemoglobin A1c 8.4%. What is the best recommendation for safe insulin pen usage?
Explanation: This question tests safe insulin pen usage practices to prevent contamination and dosing errors. The key patient-specific factor is the habit of leaving the needle attached between injections, which can introduce air or contaminants into the cartridge. Choice B is the best recommendation because removing and discarding the needle after each use maintains sterility and accuracy, with immediate sharps container disposal. Choice A is incorrect as leaving the needle attached does not improve dose accuracy and risks insulin leakage, and choice C is suboptimal due to infection risks from reusing needles. Choice D is wrong because storing the pen with the needle in a sharps container is impractical and unsafe. A transferable pearl is to always prime insulin pens before each dose to ensure proper function. Pharmacists should employ a framework: evaluate patient technique, correct misconceptions, and reinforce single-use principles.
A 50-year-old man (weight 84 kg) with type 2 diabetes reports he sometimes "tests" the insulin pen by squirting a small amount into the air with the needle attached and then throws the needle into the bathroom trash. Current medications: insulin glargine pen 26 units subcutaneously nightly, insulin aspart pen 8 units subcutaneously with meals, sitagliptin 100 mg orally daily. Allergies: none. Labs: hemoglobin A1c 8.1%. What action should the pharmacist take regarding sharps safety?
Explanation: This question evaluates pharmacist interventions for unsafe sharps practices with insulin pens. The key patient-specific factor is the patient's improper air priming and disposal of needles in bathroom trash. Choice A is the best action as it corrects disposal to sharps containers, teaches safe needle removal, and promotes pen storage without needles to prevent issues. Choice B is incorrect because recapping increases injury risk, and choice C is suboptimal as reuse heightens infection chances. Choice D is wrong since switching to vials may not be necessary or preferred. A clinical pearl is to prime pens with 2 units to confirm flow before dosing. Framework: identify errors, educate on safety, recommend best practices.
A 61-year-old man (weight 100 kg) with type 2 diabetes uses insulin pens and asks if he can dispose of needles in a detergent bottle and then place it in recycling. Current medications: insulin glargine pen 36 units subcutaneously nightly, insulin aspart pen 12 units subcutaneously with meals, metformin 1000 mg orally twice daily. Allergies: none. Labs: hemoglobin A1c 8.6%. Which instruction about sharps disposal is most important for this patient?
Explanation: This question tests appropriate use of household containers for sharps and recycling considerations. The key patient-specific factor is the proposal to use a detergent bottle for needles and recycle it. Choice B is the most important as ensuring container suitability and avoiding recycling unless permitted protects workers and complies with rules. Choice A is incorrect because recycling sharps containers is generally prohibited, and choice C is suboptimal as adding liquids does not neutralize risks. Choice D is wrong since breaking needles causes hazards. A pearl is to label containers 'Sharps - Do Not Recycle'. Use a framework: evaluate container, check recycling rules, guide alternatives.
A 37-year-old woman (weight 59 kg) is prescribed enoxaparin for 7 days after an ankle fracture and asks about the prefilled syringe air bubble. Medical history: none. Current medications: enoxaparin 40 mg subcutaneously once daily for 7 days, naproxen 500 mg orally twice daily as needed. Allergies: none. Labs: serum creatinine 0.8 mg/dL. What is the most important counseling point for a patient on enoxaparin that also supports sharps safety?
Explanation: This question assesses integrated counseling on enoxaparin use, including air bubble management and sharps safety. The key patient-specific factor is the patient's inquiry about the prefilled syringe air bubble post-ankle fracture. Choice A is the most important point as engaging the safety mechanism after injection and immediate disposal supports safety without recapping, while retaining the air bubble ensures full dose delivery. Choice B is incorrect because expelling the bubble leads to underdosing, and choice C is suboptimal as deltoid injection is not standard for enoxaparin. Choice D is wrong due to risks from delayed disposal. A pearl is to inject enoxaparin subcutaneously without expelling air for accurate dosing. Use a framework: explain technique, emphasize safety, ensure disposal.
A 28-year-old man (weight 77 kg) with type 1 diabetes is living in a dorm and asks where to put used syringes because his roommate is concerned. Current medications: insulin glargine 24 units subcutaneously nightly (vial), insulin lispro per carbohydrate counting (vial), glucagon nasal powder as needed. Allergies: none. Labs: hemoglobin A1c 7.5%. Which instruction about sharps disposal is most important for this patient?
Explanation: This question examines sharps disposal solutions for unique living situations like dorms to address roommate concerns. The key patient-specific factor is the dorm environment and roommate's discomfort with used syringes. Choice B is the most important as a secure puncture-resistant container with campus or local disposal options prevents risks and promotes compliance. Choice A is incorrect due to infection and injury risks from storage, and choice C is suboptimal without a lid for containment. Choice D is wrong as recapping and unlabeled disposal is unsafe. A pearl is to educate on biohazard labeling for shared spaces. Use a framework: assess environment, secure storage, coordinate disposal.
A 48-year-old woman (weight 70 kg) with type 1 diabetes reports she has been using a community sharps drop box but sometimes carries loose pen needles in her purse until she gets there. Current medications: insulin aspart pen 7 units subcutaneously with meals, insulin glargine pen 20 units subcutaneously nightly. Allergies: none. Labs: hemoglobin A1c 7.9%. What action should the pharmacist take regarding sharps safety?
Explanation: This question evaluates safe transport practices to community sharps drop boxes. The key patient-specific factor is carrying loose pen needles in a purse until reaching the drop box. Choice B is the best action as a portable puncture-resistant container ensures safe transport and proper transfer per program rules. Choice A is incorrect because loose needles in bags risk punctures, and choice C is suboptimal as bending increases injury potential. Choice D is wrong due to public trash disposal hazards. A pearl is to use clippers only if trained and necessary. Framework: identify transport risks, recommend container, align with program.
A 69-year-old woman (weight 58 kg) with type 2 diabetes uses insulin pens and has visual impairment. She asks how to avoid accidental needle sticks when removing pen needles. Current medications: insulin glargine pen 16 units subcutaneously nightly, insulin lispro pen 4 units subcutaneously with meals, sertraline 50 mg orally daily. Allergies: none. Labs: hemoglobin A1c 7.7%. What is the best recommendation for safe insulin pen usage?
Explanation: This question assesses techniques for safe pen needle removal in patients with visual impairments. The key patient-specific factor is the visual limitation increasing risk during needle handling for insulin pens. Choice B is the best recommendation as using the outer cap to cover before unscrewing and immediate disposal reduces stick risks. Choice A is incorrect due to direct gripping hazards, and choice C is suboptimal as inner cap recapping is not standard. Choice D is wrong because leaving attached compromises sterility. A pearl is to use tactile aids for low-vision patients. Use a framework: identify impairment, teach safe method, ensure disposal.
A 65-year-old woman (weight 72 kg) with atrial fibrillation is bridging from warfarin to enoxaparin for a procedure and will self-inject at home. Medical history: atrial fibrillation, hypertension. Current medications: warfarin 5 mg orally daily (held), enoxaparin 70 mg subcutaneously every 12 hours for 5 days, metoprolol succinate 50 mg orally daily. Allergies: none. Labs: international normalized ratio (INR) 2.4 (goal 2.0–3.0). Which instruction about sharps disposal is most important for this patient?
Explanation: This question tests sharps disposal instructions for patients on short-term enoxaparin therapy at home. The key patient-specific factor is the bridging therapy requiring self-injection and need for compliant disposal. Choice B is the most important as direct placement into a sharps container followed by community programs ensures safety and regulatory adherence. Choice A is incorrect because recycling activated syringes is not standard and risks exposure, and choice C is suboptimal due to recapping dangers. Choice D is wrong as separating components increases handling risks. A pearl is to check for mail-back programs for low-volume users. Framework: select container, use immediately, plan community disposal.
A 70-year-old man (weight 86 kg) is discharged after a hip replacement and is prescribed enoxaparin 40 mg subcutaneously once daily for 14 days for venous thromboembolism prophylaxis. Current medications: enoxaparin as above, acetaminophen 1000 mg by mouth three times daily as needed, ibuprofen 600 mg by mouth three times daily as needed, omeprazole 20 mg by mouth daily. Pertinent labs: hemoglobin 12.9 g/dL, platelets 210,000/mm3, serum creatinine 1.0 mg/dL. Allergies: none. Medical history: osteoarthritis, gastroesophageal reflux disease. What is the most important counseling point for a patient on enoxaparin?
Explanation: This question tests proper enoxaparin injection technique and sharps safety for anticoagulation therapy. The key patient-specific factor is that this post-surgical patient requires safe self-injection of enoxaparin for VTE prophylaxis. Option C is correct because avoiding needle recapping prevents needlestick injuries, and immediate disposal in sharps containers ensures safe handling of contaminated needles. Option A is incorrect because rubbing the injection site after anticoagulant administration increases bruising and bleeding risk. Option B is incorrect because the air bubble in enoxaparin prefilled syringes should be retained to ensure complete dose delivery. Option D is incorrect because enoxaparin is administered subcutaneously, not orally, making food intake irrelevant. The clinical pearl is that anticoagulant injections require special handling: retain air bubbles, avoid site manipulation, and prioritize immediate safe disposal due to bleeding risks from needlesticks.
A 44-year-old man (weight 110 kg) with type 2 diabetes is starting basal insulin with a pen device and asks how to transport used needles when traveling. Current medications: insulin glargine pen 10 units subcutaneously nightly (new start), metformin 1000 mg orally twice daily, dulaglutide 1.5 mg subcutaneously weekly. Allergies: none. Labs: hemoglobin A1c 10.2%. Which instruction about sharps disposal is most important for this patient?
Explanation: This question tests sharps disposal strategies for travelers using insulin pens to maintain safety on the go. The key patient-specific factor is the need for portable disposal solutions during travel with new basal insulin initiation. Choice A is the most important instruction as a rigid, puncture-resistant container ensures safe transport and compliance with destination regulations. Choice B is incorrect because wrapping in tissue and hotel trash risks injury to others, and choice C is suboptimal due to recapping dangers and loose storage. Choice D is wrong as breaking needles can cause injury and is not recommended. A transferable pearl is to carry a travel-sized sharps container for injectable therapies. Use a decision framework: plan for transport, select container, follow local rules.
A 52-year-old woman (weight 90 kg) with type 2 diabetes says she reuses insulin pen needles for a week to save money and sometimes notices leakage at the injection site. Current medications: insulin glargine pen 40 units subcutaneously nightly, insulin lispro pen 14 units subcutaneously with meals, pioglitazone 30 mg orally daily. Allergies: none. Labs: hemoglobin A1c 9.4%. What is the best recommendation for safe insulin pen usage?
Explanation: This question assesses safe practices for insulin pen needle use to minimize infection and mechanical issues. The key patient-specific factor is the patient's reuse of pen needles leading to leakage and potential cost-saving misconceptions. Choice B is the best recommendation as using a new needle per injection ensures sterility, accurate dosing, and proper disposal in a sharps container. Choice A is incorrect because reuse compromises sterility even if painless, and choice C is suboptimal as home sterilization is ineffective. Choice D is wrong since switching to vials does not address needle safety and may not suit the patient. A transferable pearl is to monitor injection sites for lipohypertrophy from reuse. Use a framework: assess usage habits, correct errors, and reinforce single-use benefits.
A 71-year-old woman (weight 60 kg) receives home nursing visits and uses insulin syringes for diabetes. She asks how to dispose of a growing number of used syringes because her community does not accept loose sharps in the trash. Current medications: insulin NPH 18 units subcutaneously every morning and 10 units subcutaneously every evening, regular insulin 6 units subcutaneously before meals, levothyroxine 75 mcg orally daily. Allergies: none. Labs: hemoglobin A1c 7.6%. Which instruction about sharps disposal is most important for this patient?
Explanation: This question assesses appropriate sharps disposal methods for home use when local trash rules prohibit loose sharps. The key patient-specific factor is the accumulation of used insulin syringes without a compliant disposal option in the community. Choice A is the most important instruction as it ensures containment in a puncture-resistant container and utilization of drop-off or mail-back programs per regulations. Choice B is incorrect because flushing sharps can damage plumbing and pose environmental risks, and choice C is suboptimal as a paper bag offers no puncture resistance. Choice D is wrong due to the needlestick risk during recapping and inadequate protection in a grocery bag. A transferable pearl is to label sharps containers clearly to prevent accidental access. Pharmacists should guide patients using a framework: assess local rules, select container type, and plan for final disposal.
A 34-year-old nurse comes to the pharmacy-based employee health clinic immediately after sustaining a needlestick injury from a used hollow-bore needle while drawing blood. The source patient's status is unknown, and the nurse reports being up to date on hepatitis B vaccination but is unsure of post-vaccination titers. Current medications: ethinyl estradiol/levonorgestrel 1 tablet by mouth daily. Pertinent labs available now: none. Allergies: none. Medical history: none significant. What action should the pharmacist take regarding sharps safety?
Explanation: This question tests immediate post-exposure management following occupational needlestick injury. The key patient-specific factor is the healthcare worker's immediate presentation after hollow-bore needle exposure with unknown source patient status. Option B is correct because immediate wound care (soap and water), prompt reporting per institutional protocol, and baseline testing with PEP evaluation are time-sensitive interventions that reduce infection risk. Option A is incorrect because delaying reporting compromises the effectiveness of post-exposure prophylaxis, which must be initiated within hours for HIV prevention. Option C is incorrect because caustic agents like bleach cause tissue damage without improving pathogen elimination. Option D is incorrect because recapping the contaminated needle increases injury risk and preserving the needle is unnecessary for source testing. The clinical pearl is that needlestick injuries require immediate action: wound care, reporting within 2 hours, and PEP initiation within 72 hours (ideally within 2 hours) for optimal HIV prevention.
A 42-year-old woman (weight 61 kg) with a documented latex allergy (urticaria with latex gloves) is prescribed adalimumab 40 mg subcutaneously every other week for rheumatoid arthritis and comes to the pharmacy to obtain supplies for self-injection. Current medications: adalimumab as above, methotrexate 15 mg by mouth weekly, folic acid 1 mg by mouth daily, naproxen 500 mg by mouth twice daily as needed. Pertinent labs: hemoglobin A1c 5.4% (normal), serum creatinine 0.8 mg/dL. Medical history: rheumatoid arthritis, asthma. Which factor should be considered for a patient with a latex allergy using sharps?
Explanation: This question tests management of latex allergy considerations when using injectable medications and associated supplies. The key patient-specific factor is the documented latex allergy with urticaria, requiring latex-free products for all injection supplies. Option A is correct because ensuring all components (syringes, auto-injectors, needle covers, vial stoppers, and gloves) are latex-free prevents allergic reactions while allowing safe self-injection. Option B is incorrect because routine premedication is unnecessary when latex-free products are available and doesn't address the root cause. Option C is incorrect because not all prefilled syringes are latex-free, and the choice should be based on the prescribed medication (adalimumab), not convenience. Option D is incorrect because powdered latex gloves would worsen exposure and trigger allergic reactions. The clinical pearl is that patients with latex allergies require comprehensive assessment of all injection components, including packaging and preparation supplies, to ensure complete latex avoidance.
A 55-year-old woman (weight 68 kg) is prescribed enoxaparin 1 mg/kg subcutaneously every 12 hours for acute deep vein thrombosis and will self-inject at home. Current medications: enoxaparin as above, warfarin 5 mg by mouth daily (to begin overlap), hydrochlorothiazide 25 mg by mouth daily. Pertinent labs: serum creatinine 0.7 mg/dL, baseline INR 1.0, platelets 245,000/mm3. Allergies: none. Medical history: deep vein thrombosis, hypertension. What is the most important counseling point for a patient on enoxaparin?
Explanation: This question tests proper enoxaparin injection technique for therapeutic anticoagulation dosing. The key patient-specific factor is that this patient requires therapeutic doses of enoxaparin for acute DVT treatment with proper injection technique. Option C is correct because retaining the air bubble ensures complete dose delivery, subcutaneous injection is the correct route, and immediate disposal without recapping prevents needlestick injuries. Option A is incorrect because both abdomen and thigh are acceptable sites, and site selection doesn't affect bleeding risk. Option B is incorrect because enoxaparin must be given subcutaneously, not intramuscularly, which would increase bleeding and alter pharmacokinetics. Option D is incorrect because enoxaparin-warfarin overlap is required for at least 5 days and until INR is therapeutic for 24 hours. The clinical pearl is that therapeutic enoxaparin requires precise technique: retain air bubbles for accurate dosing, inject subcutaneously at 90-degree angle, and maintain overlap with warfarin until stable therapeutic anticoagulation is achieved.
A 79-year-old woman (weight 52 kg) receives home health services and comes to the pharmacy with a coffee can containing used lancets and insulin syringes. She uses insulin NPH 18 units subcutaneously every morning and regular insulin 6 units subcutaneously with dinner; other medications include sertraline 50 mg by mouth daily and amlodipine 5 mg by mouth daily. Pertinent labs: hemoglobin A1c 7.8% (high), serum creatinine 1.3 mg/dL. Allergies: penicillin (rash). Medical history: type 2 diabetes, depression, hypertension. Which instruction about sharps disposal is most important for this patient?
Explanation: This question tests proper home sharps disposal for elderly patients using multiple sharps devices. The key patient-specific factor is that this elderly patient is currently using an inappropriate container (coffee can) for sharps disposal. Option B is correct because transferring sharps to appropriate containers (puncture-resistant, leak-resistant with tight lid) and following local disposal programs ensures safety for the patient, family, and waste handlers. Option A is incorrect because metal cans may not be leak-proof and household recycling cannot accept medical waste. Option C is incorrect because plastic bags are not puncture-resistant and capping doesn't eliminate injury risk. Option D is incorrect because breaking needles creates aerosols and sharp fragments that increase injury risk. The clinical pearl is that proper sharps containers must meet three criteria: puncture-resistant, leak-resistant, and have tight-fitting lids, with disposal through approved community programs rather than household waste streams.
A 58-year-old man (weight 102 kg) with type 2 diabetes presents to the pharmacy because his household trash service refused a bag containing used insulin pen needles. He uses insulin glargine 28 units subcutaneously nightly and insulin aspart 8 units subcutaneously with meals, plus metformin 1000 mg by mouth twice daily and lisinopril 20 mg by mouth daily. Pertinent labs: hemoglobin A1c 9.1% (high; goal typically <7%), serum creatinine 0.9 mg/dL. Allergies: no known drug allergies. Medical history: type 2 diabetes, hypertension. Which instruction about sharps disposal is most important for this patient?
Explanation: This question tests proper sharps disposal practices for home use, particularly when household trash services refuse medical waste. The key patient-specific factor is that the patient's trash service has already refused his used insulin pen needles, indicating improper disposal methods. Option B is correct because FDA-cleared sharps containers or puncture-resistant, leak-resistant containers with tight lids are the safest disposal method, and following local disposal rules ensures compliance with regulations. Option A is incorrect because clipping or breaking needles can create aerosols and increase injury risk. Option C is incorrect because recapping needles increases needlestick risk and sealed plastic bags are not puncture-resistant. Option D is incorrect because flushing sharps contaminates water systems and violates disposal regulations. The clinical pearl is that proper sharps disposal requires puncture-resistant containers and adherence to local regulations, which may include drop-off sites, mail-back programs, or special pickup services.
A 29-year-old man with type 1 diabetes (weight 72 kg) uses insulin aspart via pen and reports that his roommate sometimes uses his pen "in an emergency" by changing the needle. Current medications: insulin aspart per carbohydrate counting (typically 6–10 units subcutaneously with meals), insulin glargine 22 units subcutaneously nightly. Pertinent labs: hemoglobin A1c 7.6% (high). Allergies: none. Medical history: type 1 diabetes. What is the best recommendation for safe insulin pen usage?
Explanation: This question tests infection control principles regarding insulin pen sharing and bloodborne pathogen transmission. The key patient-specific factor is that the patient is allowing his roommate to use his personal insulin pen by changing needles. Option C is correct because insulin pens can never be shared between individuals due to biological contamination risks, as microscopic blood can enter the cartridge through backflow, creating bloodborne pathogen transmission risk even with needle changes. Option A is incorrect because changing needles doesn't prevent cartridge contamination from backflow. Option B is incorrect because testing doesn't eliminate all transmission risks and creates false security. Option D is incorrect because sterilizing the external pen doesn't address internal cartridge contamination. The clinical pearl is that insulin pens are single-patient devices due to potential blood backflow into cartridges, making sharing a serious infection control violation regardless of needle changes or cleaning procedures.
A 63-year-old man (weight 70 kg) on enoxaparin for treatment of a deep vein thrombosis asks whether he should recap the needle because he has grandchildren at home. Medical history: deep vein thrombosis, chronic kidney disease stage 3. Current medications: enoxaparin 70 mg subcutaneously every 12 hours, amlodipine 5 mg orally daily. Allergies: none. Labs: serum creatinine 1.6 mg/dL. What is the most important counseling point for a patient on enoxaparin regarding sharps safety?
Explanation: This question evaluates sharps safety counseling for enoxaparin in patients with children at home to prevent accidental injuries. The key patient-specific factor is the presence of grandchildren, prompting concerns about recapping needles. Choice B is the most important point as avoiding recapping, engaging safety devices, and immediate sharps container disposal minimizes risks, with secure storage away from children. Choice A is incorrect due to the high needlestick risk during two-handed recapping, and choice C is suboptimal as separating components increases exposure. Choice D is wrong because outdoor trash disposal does not ensure containment. A clinical pearl is to use child-resistant sharps containers in households with young children. Counsel using a framework: avoid recapping, activate safety, store securely.
A 40-year-old woman (weight 82 kg) is prescribed enoxaparin after a knee replacement and asks about injection technique and disposal. Medical history: osteoarthritis, hypertension. Current medications: enoxaparin 30 mg subcutaneously every 12 hours for 14 days, hydrochlorothiazide 25 mg orally daily, acetaminophen 1000 mg orally three times daily as needed. Allergies: none. Labs: serum creatinine 0.9 mg/dL. What is the most important counseling point for a patient on enoxaparin regarding sharps handling after injection?
Explanation: This question tests post-injection sharps handling for enoxaparin to ensure safety in home settings. The key patient-specific factor is the patient's recent knee replacement requiring self-injection, with concerns about technique and disposal. Choice B is the most important point as immediate disposal into a sharps container after injection prevents access by children or pets and reduces injury risk. Choice A is incorrect because massaging the site is not recommended for enoxaparin to avoid bruising, and choice C is suboptimal as separating components increases handling risks. Choice D is wrong due to needlestick dangers from recapping and improper storage. A transferable pearl is to keep sharps containers out of reach and sealed when not in use. Use a decision framework: counsel on injection, immediate disposal, and secure storage.